Geode Capital Management
MTEM

Geode Capital Management’s Molecular Templates, Inc. MTEM Stock Holding History

Geode Capital Management’s Portfolio MTEM Stock Details MTEM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-47,231
Closed -$66.4K – 4601
2024
Q3 		$66.4K Buy
47,231
+5,240
+12% +$7.28K ﹤0.01% 4201
2024
Q2 		$48.3K Buy
41,991
+4,562
+12% +$6.76K ﹤0.01% 4290
2024
Q1 		$83.9K Buy
37,429
+724
+2% +$2.44K ﹤0.01% 4215
2023
Q4 		$136K Hold
36,705
– – ﹤0.01% 4078
2023
Q3 		$232K Buy
36,705
+10,316
+39% +$82K ﹤0.01% 3920
2023
Q2 		$190K Hold
26,389
– – ﹤0.01% 4068
2023
Q1 		$150K Hold
26,389
– – ﹤0.01% 4173
2022
Q4 		$129K Sell
26,389
-58
-0.2% -$480 ﹤0.01% 4295
2022
Q3 		$297K Hold
26,447
– – ﹤0.01% 3995
2022
Q2 		$361K Sell
26,447
-20,668
-44% -$483K ﹤0.01% 3938
2022
Q1 		$2.44M Buy
47,115
+1,529
+3% +$67.6K ﹤0.01% 3161
2021
Q4 		$2.68M Buy
45,586
+1,792
+4% +$134K ﹤0.01% 3229
2021
Q3 		$4.41M Sell
43,794
-1,942
-4% -$200K ﹤0.01% 2979
2021
Q2 		$5.36M Buy
45,736
+8,105
+22% +$1.06M ﹤0.01% 2854
2021
Q1 		$7.12M Buy
37,631
+4,925
+15% +$864K ﹤0.01% 2594
2020
Q4 		$4.61M Buy
32,706
+1,438
+5% +$212K ﹤0.01% 2646
2020
Q3 		$5.12M Buy
31,268
+5,563
+22% +$989K ﹤0.01% 2384
2020
Q2 		$5.32M Buy
25,705
+2,275
+10% +$529K ﹤0.01% 2315
2020
Q1 		$4.67M Buy
23,430
+4,053
+21% +$887K ﹤0.01% 2196
2019
Q4 		$4.06M Buy
19,377
+4,788
+33% +$688K ﹤0.01% 2586
2019
Q3 		$1.44M Buy
14,589
+259
+2% +$24.2K ﹤0.01% 3096
2019
Q2 		$1.79M Buy
14,330
+4,862
+51% +$528K ﹤0.01% 3020
2019
Q1 		$825K Buy
9,468
+530
+6% +$38.9K ﹤0.01% 3238
2018
Q4 		$541K Buy
8,938
+3,919
+78% +$273K ﹤0.01% 3350
2018
Q3 		$405K Buy
5,019
+560
+13% +$42.9K ﹤0.01% 3542
2018
Q2 		$349K Buy
4,459
+1,554
+53% +$176K ﹤0.01% 3547
2018
Q1 		$348K Hold
2,905
– – ﹤0.01% 3521
2017
Q4 		$436K Hold
2,905
– – ﹤0.01% 3412
2017
Q3 		$303K Buy
2,905
+508
+21% +$43.9K ﹤0.01% 3527
2017
Q2 		$155K Sell
2,397
-85
-3% -$6.68K ﹤0.01% 3755
2017
Q1 		$233K Buy
2,482
+12
+0.5% +$1.12K ﹤0.01% 3601
2016
Q4 		$179K Buy
2,470
+8
+0.3% +$611 ﹤0.01% 3654
2016
Q3 		$275K Buy
2,462
+333
+16% +$45.7K ﹤0.01% 3482
2016
Q2 		$223K Sell
2,129
-374
-15% -$26.8K ﹤0.01% 3549
2016
Q1 		$189 Sell
2,503
-1
-0% -$59 ﹤0.01% 3651
2015
Q4 		$198K Buy
2,504
+68
+3% +$33.5K ﹤0.01% 3690
2015
Q3 		$1.64M Buy
2,436
+238
+11% +$169K ﹤0.01% 2568
2015
Q2 		$1.47M Buy
2,198
+77
+4% +$50.9K ﹤0.01% 2685
2015
Q1 		$1.42M Buy
2,121
+569
+37% +$375K ﹤0.01% 2662
2014
Q4 		$814K Buy
1,552
+3
+0.2% +$1.5K ﹤0.01% 2956
2014
Q3 		$922K Buy
1,549
+41
+3% +$28.4K ﹤0.01% 2821
2014
Q2 		$985K Buy
1,508
+39
+3% +$25.8K ﹤0.01% 2818
2014
Q1 		$1.15M Buy
1,469
+232
+19% +$188K ﹤0.01% 2692
2013
Q4 		$952K Buy
1,237
+14
+1% +$10.6K ﹤0.01% 2749
2013
Q3 		$939K Buy
1,223
+38
+3% +$31.2K ﹤0.01% 2630
2013
Q2 		$1.03M Buy
+1,185
New +$1M ﹤0.01% 2452

Other funds holding MTEM

Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Geode Capital Management's MTEM Position: Q4 2024 in Review

Geode Capital Management sold out of Molecular Templates, Inc. (MTEM) in Q4 2024, closing a stake of 47,231 shares — an estimated $66.4K sold.

Geode Capital Management first reported a position in MTEM in Q2 2013 and held it in 46 quarters. The position peaked at $7.12M in Q1 2021. 3 funds tracked by Wall St. Rank hold MTEM as of Q4 2024.

  • Geode Capital Management reported no remaining Molecular Templates, Inc. position as of Q4 2024 after selling out during the quarter.
  • Geode Capital Management sold 47,231 Molecular Templates, Inc. shares in Q4 2024, an estimated $66.4K.
  • Geode Capital Management first reported a position in Molecular Templates, Inc. in Q2 2013 and held it in 46 quarters.
  • Geode Capital Management's Molecular Templates, Inc. position peaked at $7.12M in Q1 2021.
  • 3 funds tracked by Wall St. Rank held Molecular Templates, Inc. as of Q4 2024.

Based on Geode Capital Management's 13F filing for Q4 2024, filed 12 Feb 2025.